RiboNova
PrivateLast Round
Grant
Dec 12, 2019
Total Funding Raised
$524,431
Company Overview
RiboNova is a biopharmaceutical company that develops small molecule drugs designed to treat serious rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RiboNova Comparables
Compare RiboNova with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribometrix | 88% | |
| Base4 Biotechnology | 86% | |
| Expansion Therapeutics | 86% | |
RiboNova Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2019 | ||||
| Grant | Dec 12, 2019 | ||||
| Seed | Jun 11, 2015 |
RiboNova Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioAdvance Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2019
$150K grant awarded by NIH RADx
RiboNova Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RiboNova's valuation, stock price, and market status.